SQSTM1 and obesity disorder: Thus, the administered p62 plasmid goes from the injection site to the bone marrow where it can transform M0 and/or M1-MF shifting them to M2-MF; then these M2-MF migrate to different tissues including AT where they alleviate inflammation, obesity and related pathologies.